Save on Rekambys with Coupons, Discounts & Savings Programs


Start Saving Today!
Lower the Cost of Your Rekambys Prescription
More great savings
View Related Generics
MEDICAL INFORMATION
Rekambys Key Facts
What is Rekambys?
Rekambys is the brand name for rilpivirine and is available as a prolonged-release suspension for injection.
What dosages is Rekambys available in?
Rekambys is available as a 3 mL vial containing 900 mg of rilpivirine and a 2 mL vial containing 600 mg of rilpivirine.
What is Rekambys used for?
Rekambys is an antiretroviral used in combination with Vocabria (cabotegravir) to treat HIV-1 infection in adults and adolescents.
How does Rekambys work?
Rekambys is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks an enzyme HIV uses to replicate, thereby helping to control the virus in the blood.
How do I take Rekambys?
Rekambys is a long-acting injectable medicine for the treatment of HIV-1, used in combination with injectable Vocabria (cabotegravir). The dosing schedule is administered by a healthcare professional as intramuscular injections into the gluteal muscle and can be either monthly or every two months.
Is it safe for me to take Rekambys?
Rekambys is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not use this medication in the following:
- Hypersensitivity to rilpivirine or to any of the excipients
- Taking certain anticonvulsants (carbamazepine, oxcarbazepine, phenobarbital, phenytoin), antimycobacterials (rifabutin, rifampicin, rifapentine), dexamethasone, and St John’s wort
Rekambys Common Side Effects
Common side effects of Rekambys:
- Injection site reactions
- Headache
- Dizziness
- Nausea
- Vomiting
- Abdominal pain
- Gas
- Diarrhea
- Insomnia
- Anxiety
- Depression
- Abnormal dreams
Rekambys Serious Side Effects
Serious side effects are rare with Rekambys. Contact your healthcare provider immediately if you experience any of the following:
- Immune reconstitution inflammatory syndrome
- Severe depression and suicidal thoughts and actions
Effects of other drugs, drug classes and over-the-counter products on Rekambys
The following medications may interact with Rekambys:
- CYP3A inhibitors or inducers
Who makes Rekambys?
GlaxoSmithKline
Is Rekambys safe in pregnancy?
Rekambys shoud only be used during pregnancy if the potential benefit justifies the potential risk. Talk to your doctor if you are already pregnant or if you have plans on becoming pregnant. They will recommend what is best for you.
What is the generic name for Rekambys?
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
OUR CUSTOMERS VIEW
What Customers Love About Our Service
We want everyone to be happy and healthy, that’s what keeps us going. Read what some of them have to say about us.
Medicines Experts
Meet Our Medical Team
We are a broad skilled and passionate group of clinicians with experience of operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process

























